Patients Paid 571 Million Euros at Portuguese Pharmacy Counters in Seven Months, While the State's Share Climbed Four Times Faster
INFARMED's July report puts patient spending at 571.6 million euros, up 2.1 percent, and the SNS share at 1,179.3 million, up 8.3 percent. The average co-payment per pack actually fell two cents. What rose was volume, and one diabetes class accounts for a third of the increase.